Delisting risk
IVF · NASDAQ · Medical - Devices

INVO Fertility (IVF)

Operates fertility clinics and sells INVOcell for intravaginal culture.

$1.03
Pre-market+0.03 (+3.00%)
At close$1.00(−0.99%)

Breakdown13F · 13D/G · Form 4

Institutions6 holders · as of Mar 31, 202610.75%192.1K shares
Insiders1 holder · as of Jan 13, 20260.00%0 shares
Strategic holders1 holder · as of Apr 1, 20267.53%134.5K shares
Otherremainder81.72%1.46M shares

1.79M company shares as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

The share count has not been confirmed by a second filing; stakes use it as it stands.

A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Glenbrook Capital ManagementStrategic
7.53%134,51513Gfiled Apr 1, 2026
Mariner, LLCInstitution
5.60%100,00013Fas of Mar 31, 2026
Armistice Capital, LLCInstitution
4.02%71,86613Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution
0.94%16,84813Fas of Mar 31, 2026
UBS Group AGInstitution
0.19%3,32113Fas of Mar 31, 2026
Citigroup IncInstitution
0.00%1513Fas of Mar 31, 2026
Sbi Securities Co., Ltd.Institution
0.00%313Fas of Mar 31, 2026
Terah Renee KrigsvoldInsiderofficer: Chief Financial Officer
0.00%0Form 4filed Jan 13, 2026
Five Narrow Lane LPStrategic
9.99% of class, as filed13Gfiled Jan 15, 2025
Matthew K. SzotInsiderdirector
0.00%0Form 4filed Dec 5, 2025

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

6 holders · 192.1K shares

HolderShares% outstandingChg q/qFiled
Mariner, LLC100.0K5.60%May 13, 2026
Armistice Capital, LLC71.9K4.02%May 15, 2026
Geode Capital Management, LLC16.8K0.94%May 15, 2026
UBS Group AG3.3K0.19%May 5, 2026
Citigroup Inc150.00%May 11, 2026
Sbi Securities Co., Ltd.30.00%Apr 28, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Five Narrow Lane LP9.99%13GJan 15, 2025
Glenbrook Capital Management8.33%134.5K13GApr 1, 2026

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Dec 3, 2025
Matthew K. Szotdirector
Sale4$1.523

CongressHouse and Senate disclosures

Not reported.